IBB ( iShares NASDAQ Biotechnology Index ETF ) tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. In this Technical Blog we’re going to take a quick look at the past Elliott Wave charts of IBB and we’re going to take a look at the price structures , count the swings and explain the forecast.
Early this year, the instrument made new highs and it was showing 5 swings from last year low which is considered as a bullish incomplete sequence. That’s why we were looking to buy the 6th swing pullback in 3 , 7 or 11 looking for a new leg to the upside or at least 3 waves bounce.
The first 3 waves pullback from March peak only gave a reaction higher, then IBB turned lower looking to do the Double Three Correction toward equal legs area 282.95 – 278.66 where buyers were expected to show up to support the Index.
On 05/31, IBB bounced perfectly from 100% of the move from 03/02 peak and then the instrument was expected to resume to the upside. The bounce higher allowed buyers to protect their position and get risk free.
Finally, the index managed to make new highs above March peak and we were still calling for more extension to the upside. The first short term target area was achieved at 321 and pullbacks from there should remain supported in 3 , 7 or 11 swings while pivot at 290 low keeps holding.